Hygeia Healthcare Holdings Co., Limited (HKG:6078)
Hong Kong · Delayed Price · Currency is HKD 8.72
-0.08 (-0.91%)
Jun 26, 2026, 4:08 PM HKT
HKG:6078 Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, HKG:6078 stock has a consensus rating of "Buy" and an average price target of $17.52. The average 1-year stock price forecast is 100.92% higher than the current stock price, while the lowest is $11.65 (+33.60%) and the highest is $25.15 (+188.42%).
Price Target: $17.52 (+100.92%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HKG:6078 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 8 | 7 | 9 | 9 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 4 | 5 | 5 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 15 | 14 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst UBS No rating | UBS | Buy Maintains $17.50 | Buy | Maintains | $17.50 | +100.69% | Jun 17, 2026 |
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Hold Maintains $14.30 → $12.50 | Hold | Maintains | $14.30 → $12.50 | +43.35% | May 29, 2026 |
Unknown Analyst China Renaissance No rating | China Renaissance | Buy Maintains $24.90 | Buy | Maintains | $24.90 | +185.55% | May 7, 2026 |
Unknown Analyst Citi No rating | Citi | Buy Maintains $23.00 | Buy | Maintains | $23.00 | +163.76% | Apr 13, 2026 |
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $18.11 | Buy | Maintains | $18.11 | +107.68% | Apr 9, 2026 |
Financial Forecast
Revenue This Year
4.33B
from 4.01B
Increased by 7.92%
Revenue Next Year
4.69B
from 4.33B
Increased by 8.43%
EPS This Year
0.87
from 0.73
Increased by 18.78%
EPS Next Year
1.02
from 0.87
Increased by 17.87%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.5B | ||
| Avg | 4.3B | ||
| Low | 4.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.3% | ||
| Avg | 7.9% | ||
| Low | -0.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.93 | ||
| Avg | 0.87 | ||
| Low | 0.75 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 27.1% | ||
| Avg | 18.8% | ||
| Low | 3.1% |